JGK-263

Overview

JGK-263 is an orally active Glycogen synthase kinase-3β ( GSK-3β ) inhibitor. JGK-263 exhibits neuroprotective effect and can improve motor function. JGK-263 can be used for the research of neurological disease , such as amyotrophic lateral sclerosis (ALS).

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > PI3K/Akt/mTOR | Products > Signaling Pathways > Stem Cell/Wnt | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GSK-3

Product Information

• Catalog No.: HY-114270
• CAS No.: 1408054-46-5
• Molecular Formula: C14H14ClN5O
• Molecular Weight: 303.75
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source